LEO Pharma , a global medical dermatology group, is acquiring US-listed Timber Pharmaceuticals, a clinical-stage biopharmaceutical company. Timber Pharmaceuticals’ lead investigational product candidate, TMB-001, is a topical reformulation of the…
LEO Pharma , a global medical dermatology group, is acquiring US-listed Timber Pharmaceuticals, a clinical-stage biopharmaceutical company. Timber Pharmaceuticals’ lead investigational product candidate, TMB-001, is a topical reformulation of the…
…
Rankings & Reports
M&A
Equity
Healthcare Investing Review
Healthcare Real Assets Report
Resources & Events
Resource Hub
Sector Events
Private Capital Conference
Real Assets Conference


